Trials / Completed
CompletedNCT03210402
REmodeling the Left Ventricle With Atrial Modulated Pacing
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
New therapy tested in heart failure with preserved ejection fraction (HFpEF) patients with approved indications for pacing to determine if elevated pacing therapy is tolerated and whether there is a signal for efficacy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Elevated night pacing on | Device will be programmed to 100 beats per minute (bpm) for five hours during normal sleep times |
| DEVICE | Elevated night pacing off | Device will be programmed to normal lower rates |
Timeline
- Start date
- 2017-09-15
- Primary completion
- 2021-03-15
- Completion
- 2021-03-15
- First posted
- 2017-07-06
- Last updated
- 2024-10-08
- Results posted
- 2024-10-08
Locations
10 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03210402. Inclusion in this directory is not an endorsement.